A detailed history of Entropy Technologies, LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 12,202 shares of RLAY stock, worth $59,667. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,202
Previous 22,809 46.5%
Holding current value
$59,667
Previous $149 Million 41.91%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$6.23 - $9.51 $66,081 - $100,872
-10,607 Reduced 46.5%
12,202 $86.4 Million
Q2 2024

Aug 12, 2024

BUY
$5.9 - $8.02 $134,573 - $182,928
22,809 New
22,809 $149 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $588M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.